peutic potential4). Thus, the addition of pentostatin enhances the antiviral and antitumor activity of vidarabine5) by preventing its deamination to the nearly inactive ara-hypoxanthine.
In our antibiotics screening program, we have discovered 2'-chloropentostatin (2-CP), a new inhibitor of adenosine deaminase ( Fig. 1 ), which is produced by a species of actinomycete belonging to the genus Actinomadura. The isolation and structure determination of this new antibiotic was first reported by SCHAUMBERG et al. 6 ) from our laboratory. Subsequently, OMURA et al.2) reported the same compound. This paper describes the assay system and biological activity of 2-CP, and the taxonomy and fermentation pattern of the organism.
Materials and Methods

Assay Organism
The test organism, Enterococcus faecalis PD 05045, an antibiotic-resistant clinical isolate, was maintained in our culture collection on Bacto-Folic acid AOAC agar medium (Difco, Detroit) containing 2.5 mg/liter of folic acid. The inoculum was prepared by growing the culture at 37°C for 18 hours on Bacto-Folic acid AOAC broth medium containing 2.5 mg/ml folic acid. The culture was centrifuged and the cells resuspended in 0.85 % saline to give a light transmittance of 20% at 555 nm, (Coleman 35 Spectrophotometer, PerkinElmer).
This suspension (1 ml) was used to inoculate 100 ml of the molten assay medium, herein designated as chloropentostatin medium (CM [ Antibiotic samples were applied onto the assay plates using 12.7 mm paper disks (Schleicher and Schuel). The plates were incubated at 37°C for 16 ~18 hours, and activity was measured as inhibitory zones.
Culture Characterization
The culture was isolated from a soil sample collected in Waynesville, N.C. The soil was subsequently plated on to an agar medium consisting of the following ingredients; glycerol 3 %, L-asparagine 0.25%, potassium chloride 0.05%, K2HPO4 0.1%, MgSO4 • 7H2O 0.05%, FeSO4.7H2O 0.001 %, and agar 1.5 %.
Culture characterization was carried out following the ISP (International Streptomyces Project) procedure7). In addition, Waksman starch agar (WSA)8) and Amidex corn starch agar (ADX)9) were used. The culture was maintained on ADX agar slants at 28°C. Morphological and color determinations of the growth of the organism were made at weekly intervals over a three-week period. Cell wall analysis was carried out following the methods of BECKER et al. 10) Fermentation Stock cultures of the organism were maintained in lyophilized vials and the working culture on ADX agar slants. The microbial growth from a two-week old slant was used to inoculate a 300-ml seed flask and incubated with shaking (New Brunswick Shaker, 5-cm throw) at 28°C. The seed medium consisted of; 0.5 % yeast hydrolysate (Amberex 1003, Amber Labs.), 0.1 % glucose monohydrate, 2.4% dextrin (Amidex B411, Corn Products), 0.5% hydrolyzed peptone (N-Z case, HumkoSheffield), 0.3 % spray dried meat solubles (Daylin Labs.), and 0.2 % CaCO3. The production of the antibiotic was carried out in 300-ml shake-flasks, 30-liter stirred-jar fermentors, and an 1,890-liter fermentor.
The production medium consisted of; 1.5% dextrin (Maltrin, Grain Processing), 1.0% lactose, 0.65% distillers solubles (Grain Processing), 0.35% peptonized milk (Humko-Sheffield), and 0.25% torula yeast (Phinelander Paper Co.). The fermentation conditions were as follows: Shake-flask, 50-ml/300-ml flask, 200 rpm shaker (Model G-53, New Brunswick Shaker); 30-liter stirred jar fermentor, 16 liters/jar, 1.0 vol of air/vol/minute, 1,890-liter fermentor, 1, 130 liters/tank, 0.375 vol of air/vol/minute (425 liters/minute), 84 rpm. The fermentation was carried out for 4~5 days at 33°C.
Biochemical and Biological Activity
The ability of 2-CP to inhibit the adenosine deaminase enzyme was evaluated following the method of CHASSIN et al.11). Briefly, the antibiotic was incubated with adenosine deaminase (EC 3.5.5.5, Type 1, Sigma Chemical Co.) for 1 hour at room temperature, and then the substrate adenosine was added. Adenosine deamination was measured by the decrease in absorbance at 265 nm as a result of the conversion of adenosine to inosine.
Results
Culture Characterization
Whole cell analyses revealed the presence of the meso isomer of 2,6-diaminopimelic acid and the sugar madurose (3-O-methyl-D-galactose). The presence of meso DAP would classify the organism as cell wall chemotype III, and the presence of madurose would assign it to maduromycetes12).
The spore chain morphology was characterized by single hooks. The organism reduced nitrate but did not liquefy gelatin nor coagulated milk; it did not produce melanin on peptone -yeast extractiron agar (ISP-6) or on tyrosine agar. Other morphological and physiological characteristics are shown in Table 1 . The carbon utilization pattern is shown in Table 2 .
The spore chain morphology produced in the aerial hyphae, in the form of hooks with no substrate spores, would further assign the organism under the genus Actinomadura. The spores were elliptical with smooth surface (Fig. 2) .
Fermentation
The production of 2-CP in the 1,890-liter fermentor was observed 24 hours after inoculation (Fig .   3 ). The inhibitory zone diameter at the 24-hour period was 42 mm vs . the assay organism, E. faecalis PD 05045. The peak production of the antibiotic was observed at the 112~ 120-hour periods , with inhibitory zone of 54 mm. The relationships of inhibitory zone and concentration of chloropentostatin is shown in Table 3 .
The growth of the organism as measured by mycelial sedimentation (15 ml fermentation broth , until the 50-hour period; afterwhich there was a rapid increase in growth reaching 96 % at the 120-hour period.
Selectivity of E. faecalis PD 05045 for 2-CP
The assay organism, E. faecalis PD 05045
was found resistant to a number of antibiotics, but was particularly sensitive to 2-CP (Table 4) .
This test organism when plated on the CM medium detected chloropentostatin level of as low as 0.005 ,ag/ml. However, 2-CP was inactive vs. the same organism when grown in Trypticase soy agar (Difco).
Also, 2-CP was inactive vs. other microorganisms grown in complex assay media, e.g., Mycin assay agar and Penassay base agar (Difco). The organisms tested include: Alcaligenes viscolactis, Micrococcus luteus, Torulopsis albida, Bacillus subtilis, Agrobacterium tumefaciens. Discussion 2'-Chloropentostatin has been demonstrated to be a tight-binding adenosine deaminase (ADA) inhibitor in vitro, similar to pentostatin3). Since the activity of ADA was found particularly high in acute lymphoblastic leukemia15), the enzyme has served as a target for chemotherapy, particularly with pentostatin16). The physiology of ADA binding to 2-CP in vivo has not been studied, which may present a subject for future investigation.
The antitumor activity of vidarabine against murine L1210 leukemia was found to be potentiated by pentostatin17). Preliminary data (LEOPOLD, W., personal communication) also indicated a chemotherapeutic synergy between vidarabine-5'-monophosphate and 2-CP, although additional studies need to be carried out to determine optimum dose combinations. In carrying out studies for optimum drug dosage and determining pharmacokinetics, quantitative assay systems are necessary to evaluate the levels and distribution of the compounds. Such assay system normally involves radiolabeled compounds. McCONNELL et al. 19) and StJLING et al.20) circumvented the use of radiolabeled compounds by the use of microbiological assay systems for both vidarabine and pentostatin. E. faecalis PD 05045 plated in the CM assay medium offers a selective and very quantitative assay for 2-CP. Interestingly, when adenine in the assay medium is deleted, the sensitivity of the organism to 2-CP is reversed; the organism becomes selectively sensitive to vidarabine and resistant to 2-CP (unpublished data). Moreover, in the CM assay medium devoid of adenine, the presence of 2-CP increased the sensitivity of E. faecalis PD 05045 toward vidarabine. Thus, this assay medium could provide an in vitro system for optimizing 2-CP-vidarabine combinations for in vivo studies.
